Cogent Biosciences (NASDAQ: COGT ) is a clinical-stage biotech focusing on genetically defined diseases with Bezuclastinib. This candidate has 3 ongoing late-stage trials for AdvSM, non-AdvSM, and GIST. I believe that If COGT is successful with these trials itMy name is Myriam Hernandez Alvarez. I received the Electronics and Telecommunication Engineering degree from the Escuela Politecnica Nacional, Quito, Ecuador, the M.Sc. degree in computer science from Ohio University, Athens, OH, USA, a graduate degre ...